Title
Recent Advances in 3D Printing for Parenteral Applications
Document Type
Article
Date of Original Version
7-1-2021
Abstract
3D printing has emerged as an advanced manufacturing technology in the field of pharmaceutical sciences. Despite much focus on enteral applications, there has been a lack of research focused on potential benefits of 3D printing for parenteral applications such as wound dressings, biomedical devices, and regenerative medicines. 3D printing technologies, including fused deposition modeling, vat polymerization, and powder bed printing, allow for rapid prototyping of personalized medications, capable of producing dosage forms with flexible dimensions based on patient anatomy as well as dosage form properties such as porosity. Considerations such as printing properties and material selection play a key role in determining overall printability of the constructs. These parameters also impact drug release kinetics, and mechanical properties of final printed constructs, which play a role in modulating immune response upon insertion in the body. Despite challenges in sterilization of printed constructs, additional post-printing processing procedures, and lack of regulatory guidance, 3D printing will continue to evolve to meet the needs of developing effective, personalized medicines for parenteral applications.
Publication Title, e.g., Journal
AAPS Journal
Volume
23
Issue
4
Citation/Publisher Attribution
Ivone, Ryan, Yan Yang, and Jie Shen. "Recent Advances in 3D Printing for Parenteral Applications." AAPS Journal 23, 4 (2021). doi: 10.1208/s12248-021-00610-z.